Farther Finance Advisors’s Oragenics OGEN Stock Holding History

Farther Finance Advisors’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	5972
2026 Q1	$1	Buy	+1	New	+$1	﹤0.01%	5745
2025 Q3	–	Sell	-1	Closed	-$4	–	5041
2025 Q2	$4	Buy	+1	New	+$5	﹤0.01%	4472
2025 Q1	–	Hold	0	–	–	–	4377

Farther Finance Advisors's OGEN Position: Q2 2026 in Review

Farther Finance Advisors held its Oragenics (OGEN) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5972.

Farther Finance Advisors first reported a position in OGEN in Q2 2025 and has held it in 3 quarters since. The position peaked at $4 in Q2 2025. 1 fund tracked by Wall St. Rank holds OGEN as of Q2 2026.

Farther Finance Advisors held 1 share of Oragenics worth $1 as of Q2 2026.
Farther Finance Advisors left its Oragenics share count unchanged in Q2 2026.
Oragenics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5972 holding.
Farther Finance Advisors first reported a position in Oragenics in Q2 2025 and has held it in 3 quarters since.
Farther Finance Advisors's Oragenics position peaked at $4 in Q2 2025.
1 fund tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.